RxDoctor Payments Data

Thanh Loan Dorsam, OD

Optometrist · Washington, DCNPI 1447319629

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 24.8% of the total. Reporting peaked in 2023 at $1,263 and has fallen 54.5% since, to $575 in 2025. Among optometrist clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,007in general payments, 2019–2025

Across 78 payments — averaging $38.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$746
  • Alcon$565
  • Glaukos Corporation$381
  • Sun Pharmaceutical Industries Inc.$264
  • Coopervision Inc.$254
  • Oyster Point Pharma, Inc.$158
  • plus $640 from 11 others

What the payments were for

  • Food & beverage$2,88096%
  • Entertainment$1274%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,007 in reported general payments places this provider in the 90th percentile of 71 optometrist providers in District of Columbia.

See all optometrist providers in District of Columbia

Medicare billing

Part B allowed, 2024
$3,042
Medicare patients
17
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →